Topics

Medulloblastoma | Etiopathogenesis | Microenvironment

Home > Publications > Topics > Medulloblastoma > Etiopathogenesis > Microenvironment

2024

Yang H, Li M, Deng Y, Wen H, Luo M, Zhang W.
Roles and interactions of tumor microenvironment components in medulloblastoma with implications for novel therapeutics.
Genes Chromosomes Cancer. 2024 Apr 12;63(4):e23233. doi: 10.1002/gcc.23233. PMID: 38607297. Review˰ ˍ

2025

Stockwell CA, Thang M, Kram DE, Satterlee AB, Hingtgen S.
Therapeutic approaches for targeting the pediatric brain tumor microenvironment.
Drug Deliv Transl Res. 2025 Apr 21. doi: 10.1007/s13346-025-01839-3. PMID: 40257744. Review˰ ˍ

2026

Chatterjee S, Kumar P, Kumar AS, Lei PJ, Datta M, Zhao Y, Ho WW, Talele NP, Andersson P, Duquette M, Kitahara S, Blanc L, Wong SJ, Kwanten WJ, Ebb DH, Yock TI, Dartois V, Fukumura D, Duda DG, Xu L, Kim HJ, Jain RK.
Targeting Tumor-derived Sphingosine Kinase 2 Unleashes Antitumor Immunity and Improves Survival of Mice with Group 3 Medulloblastoma.
bioRxiv [Preprint]. 2026 Aug 13:2026.08.12.744521. doi: 10.64898/2026.08.12.744521. PMID: 42845663. ˍ